Satraplatin in Hormone-Refractory Prostate Cancer and Other Tumour Types.
- Published in:
- Drugs, 2007, v. 67, n. 6, p. 859, doi. 10.2165/00003495-200767060-00003
- By:
- Publication type:
- Article
Works matching AU McKeage, Mark J.
Results: 24
1
2
The Effects of Synthetically Modified Natural Compounds on ABC Transporters.
- Published in:
- Pharmaceutics, 2018, v. 10, n. 3, p. 127, doi. 10.3390/pharmaceutics10030127
- By:
- Publication type:
- Article
3
Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 4, p. 847, doi. 10.1007/s00280-009-1017-6
- By:
- Publication type:
- Article
4
Antitumour action of 5,6-dimethylxanthenone-4-acetic acid in rats bearing chemically induced primary mammary tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 5, p. 661, doi. 10.1007/s00280-006-0321-7
- By:
- Publication type:
- Article
5
Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 4, p. 483, doi. 10.1007/s00280-005-0069-5
- By:
- Publication type:
- Article
6
Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
- Published in:
- 2003
- By:
- Publication type:
- journal article
7
Rapid biotransformation of satraplatin by human red blood cells in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 1, p. 9, doi. 10.1007/s00280-002-0462-2
- By:
- Publication type:
- Article
8
Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes.
- Published in:
- 2000
- By:
- Publication type:
- journal article
9
Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC.
- Published in:
- 2018
- By:
- Publication type:
- journal article
10
Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2013, v. 40, n. 6, p. 371, doi. 10.1111/1440-1681.12088
- By:
- Publication type:
- Article
11
COMPARATIVE PROTEIN BINDING, STABILITY AND DEGRADATION OF SATRAPLATIN, JM118 AND CISPLATIN IN HUMAN PLASMA IN VITRO.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2008, v. 35, n. 12, p. 1440, doi. 10.1111/j.1440-1681.2008.05017.x
- By:
- Publication type:
- Article
12
Application of liquid chromatography–mass spectrometry to monitoring plasma cyclophosphamide levels in phase I trial cancer patients*.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2004, v. 31, n. 10, p. 677, doi. 10.1111/j.1440-1681.2004.03065.x
- By:
- Publication type:
- Article
13
Capecitabine and oral cyclophosphamide: A novel oral treatment combination for advanced cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2007, v. 3, n. 2, p. 99, doi. 10.1111/j.1743-7563.2007.00095.x
- By:
- Publication type:
- Article
14
Emerging roles of metal solute carriers in cancer mechanisms and treatment.
- Published in:
- Biopharmaceutics & Drug Disposition, 2014, v. 35, n. 8, p. 450, doi. 10.1002/bdd.1903
- By:
- Publication type:
- Article
15
Role of platinum DNA damage-induced transcriptional inhibition in chemotherapy-induced neuronal atrophy and peripheral neurotoxicity.
- Published in:
- Journal of Neurochemistry, 2015, v. 135, n. 6, p. 1099, doi. 10.1111/jnc.13355
- By:
- Publication type:
- Article
16
Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non‐small‐cell lung cancer in New Zealand.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 6, p. 716, doi. 10.1111/imj.14435
- By:
- Publication type:
- Article
17
Clinical Trials of Vascular Disrupting Agents in Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 3, p. 143, doi. 10.1016/j.cllc.2011.03.010
- By:
- Publication type:
- Article
18
Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.
- Published in:
- Molecular Pain, 2010, v. 6, n. 1, p. 53, doi. 10.1186/1744-8069-6-53
- By:
- Publication type:
- Article
19
Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics.
- Published in:
- Expert Opinion on Drug Metabolism & Toxicology, 2016, v. 12, n. 12, p. 1479, doi. 10.1080/17425255.2016.1223625
- By:
- Publication type:
- Article
20
Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients.
- Published in:
- 2013
- By:
- Publication type:
- journal article
21
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 496, doi. 10.1186/1471-2407-12-496
- By:
- Publication type:
- Article
22
Detecting acute neurotoxicity during platinumchemotherapy by neurophysiological assessmentof motor nerve hyperexcitability.
- Published in:
- BMC Cancer, 2010, v. 10, p. 451, doi. 10.1186/1471-2407-10-451
- By:
- Publication type:
- Article
23
Hormone resistance in two MCF-7 breast cancer cell lines is associated with reduced mTOR signaling, decreased glycolysis, and increased sensitivity to cytotoxic drugs.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00221
- By:
- Publication type:
- Article
24
Disrupting Established Tumor Blood Vessels.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 8, p. 1859, doi. 10.1002/cncr.24975
- By:
- Publication type:
- Article